DaVita Financial Statements (DVA)
|
|
Report date
|
|
|
21.02.2020 |
12.02.2021 |
11.02.2022 |
22.02.2023 |
14.02.2024 |
|
29.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
11 388 |
11 551 |
11 619 |
11 610 |
12 140 |
|
12 667 |
Operating Income, bln rub |
|
|
1 643 |
1 695 |
1 797 |
1 339 |
1 603 |
|
1 930 |
EBITDA, bln rub |
? |
|
2 371 |
2 314 |
2 451 |
2 045 |
2 346 |
|
2 596 |
Net profit, bln rub |
? |
|
811.0 |
773.6 |
978.5 |
768.2 |
691.5 |
|
827.7 |
|
OCF, bln rub |
? |
|
2 072 |
1 979 |
1 931 |
1 565 |
2 059 |
|
1 965 |
CAPEX, bln rub |
? |
|
766.5 |
674.5 |
641.5 |
603.4 |
568.0 |
|
543.8 |
FCF, bln rub |
? |
|
1 306 |
1 304 |
1 289 |
961.1 |
1 491 |
|
1 421 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
1 718 |
1 878 |
1 876 |
2 088 |
1 474 |
|
1 712 |
Cost of production, bln rub |
|
|
7 914 |
7 989 |
7 972 |
8 210 |
8 320 |
|
8 882 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
443.8 |
304.1 |
285.3 |
357.0 |
398.6 |
|
427.9 |
|
Assets, bln rub |
|
|
17 311 |
16 989 |
17 121 |
16 928 |
17 619 |
|
17 504 |
Net Assets, bln rub |
? |
|
2 133 |
1 384 |
755.5 |
712.3 |
1 056 |
|
386.7 |
Debt, bln rub |
|
|
11 176 |
11 194 |
11 975 |
11 822 |
11 116 |
|
12 198 |
Cash, bln rub |
|
|
1 114 |
345.1 |
484.2 |
321.8 |
391.7 |
|
1 092 |
Net debt, bln rub |
|
|
10 062 |
10 849 |
11 491 |
11 501 |
10 725 |
|
11 106 |
|
Ordinary share price, rub |
|
|
75.0 |
117.4 |
113.8 |
74.7 |
104.8 |
|
77.9 |
Number of ordinary shares, mln |
|
|
153.2 |
119.8 |
105.2 |
93.0 |
90.8 |
|
83.7 |
|
Market cap, bln rub |
|
|
11 493 |
14 064 |
11 971 |
6 944 |
9 511 |
|
6 519 |
EV, bln rub |
? |
|
21 555 |
24 913 |
23 462 |
18 444 |
20 236 |
|
17 625 |
Book value, bln rub |
|
|
-4 790 |
-5 702 |
-6 468 |
-6 547 |
-6 260 |
|
-7 039 |
|
EPS, rub |
? |
|
5.29 |
6.46 |
9.30 |
8.26 |
7.62 |
|
9.89 |
FCF/share, rub |
|
|
8.52 |
10.9 |
12.3 |
10.3 |
16.4 |
|
17.0 |
BV/share, rub |
|
|
-31.3 |
-47.6 |
-61.5 |
-70.4 |
-68.9 |
|
-84.1 |
|
EBITDA margin, % |
? |
|
20.8% |
20.0% |
21.1% |
17.6% |
19.3% |
|
20.5% |
Net margin, % |
? |
|
7.12% |
6.70% |
8.42% |
6.62% |
5.70% |
|
6.53% |
FCF yield, % |
? |
|
11.4% |
9.28% |
10.8% |
13.8% |
15.7% |
|
21.8% |
ROE, % |
? |
|
38.0% |
55.9% |
129.5% |
107.8% |
65.5% |
|
214.0% |
ROA, % |
? |
|
4.68% |
4.55% |
5.71% |
4.54% |
3.92% |
|
4.73% |
|
P/E |
? |
|
14.2 |
18.2 |
12.2 |
9.04 |
13.8 |
|
7.88 |
P/FCF |
|
|
8.80 |
10.8 |
9.28 |
7.22 |
6.38 |
|
4.59 |
P/S |
? |
|
1.01 |
1.22 |
1.03 |
0.60 |
0.78 |
|
0.51 |
P/BV |
? |
|
-2.40 |
-2.47 |
-1.85 |
-1.06 |
-1.52 |
|
-0.93 |
EV/EBITDA |
? |
|
9.09 |
10.8 |
9.57 |
9.02 |
8.62 |
|
6.79 |
Debt/EBITDA |
|
|
4.24 |
4.69 |
4.69 |
5.62 |
4.57 |
|
4.28 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
6.73% |
5.84% |
5.52% |
5.20% |
4.68% |
|
4.29% |
|
DaVita shareholders |